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 Introduction 
 With advancing age, the cognitive abilities of many 
people decline to some degree  [1] . Those mild cognitive 
deﬁ cits are unspeciﬁ c and heterogeneous regarding aetiol-
ogy and course  [2] . Often, they do not progress or even 
improve. However, in old age the probability increases 
that cognitive deﬁ cits are due to Alzheimer’s disease (AD) 
or another illness which leads to the manifestation of a 
dementia syndrome  [3, 4] . 
 Clinically, the different types cannot be accurately dif-
ferentiated or predicted. Accurate biomarkers of the most 
frequent dementing illnesses (in particular AD) are still 
lacking  [5] . Moreover, there is no established consensus 
on diagnostic criteria and clinical labels  [6–9] . One meth-
od for deﬁ ning mild cognitive deﬁ cits involves the use of 
dementia severity rating scales, which all include preclin-
ical forms of dementia  [9] . So-called ‘questionable de-
mentia’ (QD) refers to a score of 0.5 in the Clinical De-
mentia Rating (CDR)  [10] . 
 There is evidence that volumetric brain measures can 
support the early diagnosis of dementing illnesses. Sev-
eral longitudinal neuroimaging studies in individuals 
without dementia showed that the volume of temporal 
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stable in cognition or of improving. We investigated 
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items of the Mini-Mental State Examination. Global brain 
volume, grey matter volume and white matter volume 
were the only signifi cant independent predictors of the 
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areas and particularly the hippocampus is associated with 
the subsequent development of dementia (see recent re-
views)  [11–13] . However, this association is only moder-
ate and seems not satisfactory for clinical purposes and 
the assessment of isolated cases  [12] . Whether other vol-
umetric parameters such as global brain volume or cal-
losal size have any predictive value, has rarely been in-
vestigated. First longitudinal ﬁ ndings regarding the glob-
al brain volume are encouraging  [14–18] . 
 In almost all neuroimaging studies, the question has 
been neglected whether volumetric measures are inde-
pendent predictors. Only a minority of neuroimaging 
studies reported ﬁ ndings in direct comparison with neu-
ropsychological tests  [12] . However, neuropsychological 
tests, particularly measures of memory, are associated 
with the development of dementia  [19] . In patients with 
AD, impaired cognition is supposed to be caused by neu-
ropathological changes and by the resulting atrophy  [20] . 
Because of this link, neuropsychological and volumetric 
measures may yield corresponding diagnostic informa-
tion. For clinical purposes, it might be redundant or inef-
fective to measure both. 
 This prospective longitudinal study investigates 
whether global brain volume, hippocampal volume and 
callosal size are independent predictors of a future change 
in cognitive function in elderly subjects without dementia 
(individuals with normal cognition and individuals with 
QD). The hypothesis is that smaller volumes are associ-
ated with accelerated cognitive decline. 
 Methods 
 Participants 
 The longitudinal study was initiated in August 1997. 74 par-
ticipants without dementia (age range 73–87 years) were enrolled. 
Most participants (n = 68) were consecutively recruited for this 
study from the Leipzig Longitudinal Study of the Aged (LEILA75+) 
 [21] . To ensure that participants represented a cognitive continu-
um, they were recruited according to Mini-Mental State Examina-
tion (MMSE) strata  [22] . They represented approximately 10% of 
the non-demented LEILA75+ sample in the same age range. Six 
additional non-demented participants were consecutively recruited 
from the local memory clinic, the inclusion criteria were a CDR 
score of 0.5 (see below) and age between 75 and 85 years. All of 
them had subjective memory complaints. 30% of the sample re-
cruited by LEILA75+ had subjective memory complaints. Written 
informed consent was obtained from all participants after complete 
description of the study. All participants were clinically investi-
gated as described previously  [22] . Presence of signs of depression 
were rated using the Montgomery-Asberg Depression Rating Scale 
(MADRS)  [23] . Cognitive skills were assessed based on the test 
performance part of the Structured Interview for the Diagnosis of 
Dementia of the Alzheimer-type, Multi-infarct Dementia and De-
mentias of other aetiologies according to ICD-10 and DSM-III-R 
(SIDAM)  [24] . This neuropsychological screening instrument con-
sists of 55 items, including all 30 items of the MMSE  [25] . It allows 
the investigation of the following domains: orientation, immediate 
recall, delayed recall, long-term memory, intellectual abilities, ver-
bal abilities/calculation, visuospatial function and aphasia/apraxia. 
In cases with cognitive deﬁ cits, a relative was interviewed. The de-
gree of cognitive impairment was rated using the CDR, which com-
prises the scales memory, orientation, judgement and problem solv-
ing, community affairs, home and hobbies as well as personal care 
 [10] . The CDR was scored independently of the psychometric as-
sessment. According to the CDR rates, participants were classiﬁ ed 
in two groups: 39 cognitively normal controls (CDR = 0) and 35 
patients with QD (CDR = 0.5). Participants with QD typically suf-
fered from mild forgetfulness, they were fully oriented, had no or 
slight impairment in social functions and did not meet ICD-10 de-
mentia criteria. None of the participants had a history of a major 
psychiatric illness or Parkinson’s disease based on medical history. 
Mild depressive symptoms did not lead to exclusion from the 
study. 
 Magnetic Resonance Imaging 
 Participants were investigated by a 1.5-tesla tomograph (Sie-
mens Vision) with a volumetric T 1 -weighted MPRAGE sequence 
(TR 11.4 ms, TE 4.4 ms, 128 slices, orientation transverse, matrix 
256  ! 256, voxel size 0.9  ! 0.9  ! 1.5 mm) and by a T 2 -weighted 
protocol (TR 5,016 ms; TE 132 ms; 19 slices, thickness 5 mm; ori-
entation transverse, 1-mm gap; matrix 357  ! 512, voxel size
0.5  ! 0.5  ! 6 mm). Data sets were analysed using the BRIAN 
software package  [26] . The volumetric data sets were aligned with 
the stereotactic co-ordinate system  [27] , using the anterior and pos-
terior commissure as reference points and scaled to an isotropic 
voxel resolution of 1 mm. 
 From the whole three-dimensional data set grey and white mat-
ter, internal and external cisterns (cerebrospinal ﬂ uid compart-
ments, CSF) were automatically determined using a boundary-
guided region-growing procedure  [28] . Intracranial volume (ICV) 
was deﬁ ned as the sum of total brain volume and CSF volume. Six 
cross sections of the hippocampus were segmented manually in the 
coronal plane on both sides. Hippocampal measures started behind 
the amygdala at the slice in which the area of the hippocampal head 
appeared maximal and were continued posteriorly at 3-mm inter-
vals  [22] . The corpus callosum was outlined manually in the sagit-
tal slice best representing the midsagittal plane (little or absent grey 
matter and a visible septum pellucidum)  [29] . Manual outlining 
techniques have previously been shown to have a high inter-rater 
reliability. For hippocampal size, intraclass correlation was 0.996 
 [22]; the average difference between the hippocampal measures of 
2 raters did not differ signiﬁ cantly from 0. For the corpus callosum, 
intraclass correlation was 0.918  [30] , the average inter-rater differ-
ence also did not differ signiﬁ cantly from 0. 
 Based on the t 2 -weighted images, white matter changes were as-
sessed. Using a 4-point scale (0 = absent, 1 = mild, 2 = moderate, 
3 = severe), the degree of periventricular white matter hyperinten-
sities (PVH), deep white matter hyperintensities (DWMH) and di-
lated perivascular spaces (DPS) was rated. Intrarater experiments 
(by H.W.) demonstrated a high reliability with kappa values of 0.88 
for DPS, 0.92 for DWMH and 0.95 for PVH  [31] . 
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 Follow-Up 
 Participants were re-examined after a mean of 2.3 years (SD 
0.62, range 1–4 years). Again participants were investigated clini-
cally and cognitive skills were assessed using SIDAM. Changes in 
cognitive functions were determined by subtracting the baseline 
SIDAM score (SISCO) from the follow-up SISCO and then this dif-
ference was divided by the follow-up interval: annual change in 
SISCO = (follow-up SISCO – baseline SISCO)/follow-up interval. 
Accordingly, the annual change in MMSE score was computed. 
 Three groups were formed according to the outcome: (1) decline 
(participant declined at least 1.5 points/year); (2) stability (partici-
pant changed less than 1.5 points/year); (3) improvement (partici-
pant improved at least 1.5 points/year). To ﬁ nd an appropriate 
cutoff, this study relied on the 1-standard deviation (SD) interval 
of the annual change in SISCO, as it proved to be normally distrib-
uted. The cutoff at 1.5 points/year marks quite accurately the lim-
its of 1 SD. It includes 69% of the sample (see ‘Results’). Longitu-
dinal studies of the ‘normal’ change in SISCO are lacking. How-
ever, the MMSE was found to decline by 0.9 points on average in 
men and by 1.0 point in women during 5 years and by 1.3 points 
over 28 months  [32, 33] . 
 Statistical Analysis 
 All statistical computations were performed using SPSS for 
Windows (version 8.0.0). The signiﬁ cance level was set to be 0.05 
for all analyses. Baseline characteristics were compared using U test 
or Kruskal-Wallis-H. Normal distribution of the annual change in 
SISCO and the annual change in MMSE was tested using Kolmogo-
rov-Smirnov test. Differences between the control group and the 
QD group in the average annual change in SISCO were tested using 
U test, variance homogeneity was tested using F test by Levene. To 
make volumes of brain structures comparable – which are different 
in size – and to make men and women comparable, measures were 
z-transformed separately for each gender. Repeated stepwise back-
ward linear regression analyses were performed to predict the an-
nual change in SISCO. Firstly, only clinical and psychometric vari-
ables were included (model 1). Secondly, z-transformed volumetric 
brain measures were additionally included; namely in those com-
binations in which they were only moderately associated with each 
other (r  ! 0.7) to avoid collinearity (models 2–4). The interdepen-
dence of the predictor variables was examined by correlation anal-
yses, the alpha level was adjusted for multiple testing by Bonfer-
roni-Holm. In all regression analyses and correlation analyses one 
extreme case has been excluded to produce normal distribution. 
Because the exclusion of an outlier can distort the results, all ﬁ nd-
ings were double-checked. For that purpose the outlier was includ-
ed and the outcome variable was logarithmically transformed. Re-
sults were essentially the same. Group differences in volumetric 
brain measures were compared by analyses of variance (ANOVA) 
with group as a factor and ICV as a covariate. The alpha level was 
again adjusted for multiple testing by Bonferroni-Holm. 
 Results 
 Table 1 summarises the baseline characteristics of the 
control group and of the QD group. Both groups differed 
signiﬁ cantly from each other in the baseline MMSE (U = 
104.5, n = 74, p  ! 0.001), the baseline SISCO (U = 91.0, 
n = 74, p  ! 0.001) and years of education (U = 403.0,
n = 74, p = 0.002). The difference in MMSE and SISCO 
was still signiﬁ cant when the inﬂ uence of education on 
test performance was controlled for by means of regres-
sion analysis. Groups did not differ in age or in length of 
the follow-up interval. Signs of depression were slightly 
more frequent in the QD group, but the difference was 
not signiﬁ cant. ANOVA with group as a factor and ICV 
as a covariate showed that control participants had sig-
niﬁ cantly larger hippocampal volumes than participants 
with QD: z-transformed left hippocampus (F 1, 71  = 11.7, 
p  ! 0.01), z-transformed right hippocampus (F 1, 71  = 10.8, 
p  ! 0.01). The control group and the QD group did not 
differ signiﬁ cantly in any other volume. The majority of 
control participants and of QD participants had white 
matter changes. Chi-square test showed no group differ-
ence. Out of 74 participants, mild to moderate DPS were 
found in 70% of the cases, severe DPS in 20%. Mild to 
moderate PVH was present in 80% of the participants, 
severe PVH in 16%. Mild to moderate DWMH was seen 
in 70% of the participants, severe DWMH in 10%. 
Table 1. Baseline characteristics of the control group and the QD 
group (n = 74)
Controls QD
(n = 39) (n = 35)
Female 22 (56.4%) 26 (74.3%)
Age, years 79.482.9 79.983.3
Education, years1 12.582.3 10.881.9
MMSE1 28.981.1 26.281.8
SISCO1 51.182.8 45.183.5
MADRS median 3 3
MADRS 25th–75th percentile 0–6      2–10
Left hippocampus2 0.3880.93 –0.4280.90
Right hippocampus2 0.3780.84 –0.4181.00
Corpus callosum 0.0981.01 –0.1080.98
ICV 0.1580.98 –0.1781.00
Brain volume 0.1381.07 –0.1580.89
White matter volume 0.1381.11 –0.1580.83
Grey matter volume 0.1281.06 –0.1380.91
Internal CSF volume –0.1280.56 0.1381.32
External CSF volume 0.1681.01 –0.1880.95
Data are given as mean 8 SD (except for MADRS). All brain 
measures have been z-transformed. SISCO = Score of the test per-
formance part of the Structured Interview for the Diagnosis of 
Alzheimer’s Dementia and Multi-Infarct Dementia. 
1U test showed a signiﬁ cant difference between the groups.
2ANOVA showed a signiﬁ cant difference between the groups.
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 Out of 74 participants at baseline, 68 participants were 
followed up (37 controls, 31 QD). Six participants were 
lost because of death (n = 3), inability to contact (n = 1) 
or refusal (n = 2). U test showed that participants who 
dropped out did not differ from participants who were 
followed up in age, years of education, MMSE or SIS-
CO. 
 Four women (all had initially QD) were diagnosed as 
having dementia at follow-up. According to ICD-10 cri-
teria, 3 had mild dementia in AD, 2 of them were diag-
nosed as atypical or mixed type. One participant with a 
severe dementia syndrome was shielded by her relatives. 
According to the medical records, her dementia syndrome 
was caused by multiple strokes, i.e. vascular dementia. 
She had experienced an extreme change in test perfor-
mance in SIDAM (–14 points/year). 
 At follow-up, CDR scoring was done in 55 cases (31 
controls, 25 QD). In the remaining 13 probands CDR 
scoring would not have been reliable, because interviews 
with relatives were not possible. All 31 controls, who were 
again assessed with the CDR, received again a CDR glob-
al score of 0. Out of 25 probands with QD at baseline, 5 
improved to a CDR global score of 0, 15 received again 
a CDR score of 0.5 and 4 a CDR score  6 1. Because of 
the missing values and the resulting lack of statistical 
power, we decided not to add the CDR as an outcome 
variable. 
 Out of the 68  participants that were followed, most 
participants (69%) experienced a small change in SISCO 
( ! 1.5 points/year). Thirteen percent improved more 
than 1.5 points/year, 18% declined more than 1.5 points/
year. The control group proved to be signiﬁ cantly more 
steady in cognitive function than the QD group ( ﬁ g. 1 ). 
Only 14% of the control group changed more than 1.5 
points/year, whereas 52% of the QD group did. Accord-
ingly, the degree of variance of the annual change in SIS-
CO ( table 2 ) was signiﬁ cantly smaller in the control group 
(F = 11.5, p = 0.001). There was no signiﬁ cant difference 
in the average change in MMSE and in the average 
change in SISCO between the control group and the QD 
group. 
 Coefﬁ cients of the regression models which signiﬁ -
cantly explained the annual change in SISCO are listed 
in  table 3 . Older age, a higher CDR sum score and sur-
prisingly also a higher baseline SISCO were signiﬁ cantly 
associated with decline in cognitive function (model 1). 
Gender as well as years of education lacked association 
to the annual change in SISCO. Of all brain measures, 
only the z-transformed total brain volume, grey matter 
and white matter volume (models 2–4) were signiﬁ cant 
Table 2. Average annual change in MMSE and in SISCO (n = 68)
Controls QD
(n = 37) (n = 31)
Change in MMSE 0.080.5 –0.681.9
Change in SISCO 0.281.2 –0.983.3
Data are given as mean 8 SD.
Table 3. Signiﬁ cant predictors of annual change in SISCO (n = 67)
Model Standardised
beta
p Correc-
ted R2
1 baseline CDR sum score –0.72 0.000 0.23
baseline SIDAM score –0.63 0.000
age –0.24 0.033
2a + grey matter volume –0.25 0.021 0.28
3a + total brain volume –0.24 0.032 0.28
4a, b + white matter volume –0.20 0.084 0.26
a Models 2–4 also include the CDR sum score, SIDAM score 
and age. Their coefﬁ cients are not reported to avoid redundan-
cies.
 b If age is excluded, white matter volume is a signiﬁ cant predic-
tor with p = 0.025.
Fig. 1. The annual change in the test performance in SIDAM in 
individuals with normal cognition and patients with questionable 
dementia (QD) followed up over 2.3 years (n = 68). A change of 1.5 
points per year was used as a cutoff for the deﬁ nition of the three 
outcome groups. 
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independent predictors and improved the proportion of 
explained variance achieved by model 1. 
 There was some interdependence between the predic-
tor variables. Naturally, the z-transformed volumetric 
measurements of several brain compartments correlated 
strongly with each other ( table 4 ). It was therefore unrea-
sonable to include all brain measures simultaneously in 
one regression model to predict the annual change in SIS-
CO. Moreover, the baseline SISCO correlated signiﬁ cant-
ly with the CDR sum score (r = –0.66, n = 67, p  ! 0.001), 
the left hippocampal volume (r = 0.39, n = 67, p  ! 0.001) 
and the right hippocampal volume (r = 0.33, n = 67, p  ! 
0.001). Analogous, the CDR sum score correlated signif-
icantly with the left hippocampal volume (r = –0.41, n = 
Table 4. Pearson’s correlation coefﬁ cients between volumetric brain measures (n = 67)
Left HC Right
HC
CC ICV Total
brain
Internal
CSF
External
CSF
White
matter
Grey 
matter
Left HC 1
Right HC 0.79a 1
CC 0.15 0.10 1
ICV 0.36a 0.37a 0.47a 1
Total brain 0.40a 0.38a 0.48a 0.81a 1
Internal CSF 0.05 0.04 –0.20 0.22 0.16 1
External CSF 0.10 0.16 0.26 0.56a 0.03 –0.22 1
White matter 0.31 0.31 0.54a 0.67a 0.92a 0.12 –0.06 1
Grey matter 0.45a 0.40a 0.36a 0.82a 0.93a 0.19 0.11 0.73a 1
All brain measures have been z-transformed. HC = Hippocampus; CC = corpus callosum. Because multiple 
analyses were computed, the alpha level was adjusted by means of Bonferroni-Holm.
a Correlation is signiﬁ cant at the adjusted alpha level (one-tailed).
Decline Stability Improve-
ment
(n = 12) (n = 47) (n = 9)
Initial QD 10 (83.3%) 15 (31.9%) 6 (66.7%)
Female 11 (91.7%) 28 (59.6%) 5 (55.6%)
Age, years1 81.683.4 79.483.1 78.682.2
MMSE1 26.582.2 28.381.2 25.483.0
SISCO1 45.885.1 49.783.1 43.485.1
Education, years 10.582.1 11.882.3 12.682.3
MADRS median 3 2 3
MADRS 25th–75th percentile  1–7  1–7  0–5
Left hippocampus –0.3581.09 0.2280.98 –0.3680.41
Right hippocampus –0.2081.26 0.1180.92 –0.1480.68
Corpus callosum –0.2781.17 0.0480.99 0.2680.78
ICV –0.2681.26 0.0280.98 0.5180.78
Brain volume –0.3081.15 0.1481.04 0.2180.47
White matter volume –0.3081.13 0.1381.02 0.0580.64
Grey matter volume –0.2681.10 0.1281.03 0.3280.41
Internal CSF volume 0.1481.40 0.0880.97 –0.3380.61
External CSF volume –0.0881.23 –0.1580.82 0.6081.16
Data are given as mean 8 SD. All brain measures have been z-transformed. 
1Kruskal-Wallis H testing showed a signiﬁ cant difference between the three groups at 
the 0.05 level.
Table 5. Baseline characteristics of the 
three outcome groups (n = 68)
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67, p  ! 0.001) and the right hippocampal volume (r =
–0.38, n = 67, p  ! 0.001) as well as with the years of edu-
cation (r = –0.33, n = 67, p  ! 0.001). 
 Baseline characteristics of the three outcome groups 
decline, stability, and improvement are summarised in 
 table 5 . Participants who declined as well as participants 
who improved both had signiﬁ cantly lower baseline 
MMSE and baseline SISCO than stable participants and 
did not differ from each other. This corresponds to the 
fact that most decliners and most improvers had been 
diagnosed as QD at baseline. Improvers were signiﬁ cant-
ly younger and completed more years of education than 
decliners. All brain structures as well as the external CSF 
were larger in the improvement group than in the decline 
group, except the left hippocampus. The internal CSF was 
largest in the decline group. However, ANOVA showed 
no signiﬁ cant group effect in any brain structure. Chi-
square test showed that the three outcome groups did not 
differ in the degree of white matter changes. Moreover, 
they did not differ in the length of the follow-up interval 
or in the degree of signs of depression. 
 Discussion 
 In the current study we investigated whether global 
brain volume, callosal size and hippocampal size are in-
dependently associated with the rate of cognitive change 
in elderly subjects without dementia, i.e. individuals with 
normal cognition and individuals with QD. 
 39 cognitively normal participants and 35 participants 
with QD were included. The QD group can be assumed 
to be heterogeneous regarding the aetiology of cognitive 
impairment. According to present knowledge, it is likely 
that most QD patients suffered from very mild AD  [34, 
35] . In other participants with QD, cognitive impairment 
might have been related to age and to vascular changes. 
Accordingly, the participants experienced different cours-
es of cognitive change. Most participants remained almost 
steady in cognitive function and changed not more than 
1.5 points/year in SISCO. There was a small variance in 
the outcome variable. Parallel to this steadiness, the as-
sociation between the predictor variables and the out-
come was moderate. The maximal proportion of explained 
variance of the annual change in SISCO was 28%. 
 The proportion of participants who experienced cogni-
tive decline during the study corresponds to previous re-
ports. 11.4% of the QD group (n = 4) developed a demen-
tia syndrome. Petersen et al.  [36] reported conversion 
rates to dementia between 10 and 15%, other reviews re-
ported conversion rates up to 25%  [9, 37] . Considering 
the sample characteristics and the outcome, the results 
can be interpreted in the light of knowledge about AD. 
 Among all brain measures, only global brain volume, 
grey matter volume and white matter volume were sig-
niﬁ cant independent predictors of the annual change in 
SISCO. One explanation for this superiority might be that 
a reduction of global brain volume is linked with a more 
advanced stage of AD than atrophic changes of midtem-
poral areas, which occur at earlier stages. The neuro-
pathological studies by Braak and Braak  [38]  showed that 
neuroﬁ brillary tangles – one feature of AD – evolve in six 
typical stages and that they spread out in non-limbic cor-
tical regions at later stages of the disease. This ‘neocortical 
stage’ is related to the development of dementia, although 
there is evidence that some patients develop dementia 
without involvement of the neocortex  [20, 39, 40] . Mem-
ory deﬁ cits that are already present before the onset of a 
dementia syndrome seem to be related to the spreading 
of neuroﬁ brillary tangles into midtemporal (limbic) areas 
 [20] . The hippocampus is affected in this so-called ‘limbic 
stage’. 
 Other explanations for the superiority of global brain 
volume measures are their ‘non-speciﬁ city’ regarding the 
location of brain tissue loss and the so-called ‘reserve hy-
pothesis’. Because global brain volume is sensitive to 
atrophic changes independently of their location, it is able 
to indicate the general state of the brain. This is important 
because recently evidence was provided showing that cog-
nitive decline in mild cognitive impairment is associated 
with global brain damage  [41] . Hippocampal volume and 
callosal size are more speciﬁ c measures and indicate only 
changes in localised regions. The reserve hypothesis im-
plies that a larger premorbid brain size protects against 
the effects of ageing and AD. Total brain, grey and white 
matter volume represent to some degree the premorbid 
brain size. The theory is discussed controversially. Both 
indication for its validity was found  [42, 43] and negative 
results have been reported  [44] . 
 In conclusion, the results of this study suggest that 
global measures of brain volume are associated with fur-
ther cognitive change in patients with QD and in indi-
viduals with normal cognition. This is in line with previ-
ous longitudinal neuroimaging studies. Fox et al.  [14] 
 found increased rates of cerebral atrophy in patients sub-
sequently developing dementia. Fischl et al.  [15] found 
that patients with stable QD differed in all ventricular 
substructures from patients with progressive QD. Analo-
gous to our study, Forstl et al.  [16] showed that the rate 
of change in MMSE is associated to the degree of brain 
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atrophy in patients with age-associated memory impair-
ment and with AD. Mungas et al.  [17]  reported that atro-
phy of the cortical grey matter predicted a cognitive de-
cline in individuals without dementia and with AD. Mar-
quis et al.  [18]  found reduced total brain volume in healthy 
participants who subsequently converted to a CDR score 
of 0.5 or more. Also cross-sectional studies reported re-
duced global volume parameters in patients with mild 
cognitive impairment  [45, 46] . 
 By way of contrast, our results contradict previous lon-
gitudinal studies of the predictive value of hippocampal 
volume. Reviews of a great number of recent publications 
indicate that in individuals with mild cognitive deﬁ cits 
initial hippocampal volume is moderately associated 
with the future development of AD  [11, 12] . The differ-
ence to this study might be due to a difference in outcome 
variables. Most of previous studies have aimed to predict 
dementia in AD, while this study aimed to predict the 
rate of change in a neuropsychological test. The clinical 
relevance of this outcome measure is emphasised by the 
ﬁ nding that accelerated cognitive decline is a feature of 
dementing illnesses, though there is great variability in 
the rate of change in patients with AD  [47] . In 8 out of 
12 cases with accelerated cognitive decline no dementia 
syndrome had been diagnosed at the follow-up visit. Con-
sequently, the level of cognitive function was on average 
higher in this group than in groups consisting exclusively 
of patients with dementia. In principle, SISCO mirrored 
hippocampal function, as both measures correlated sig-
niﬁ cantly with each other at baseline. In conclusion, this 
study indicates that hippocampal atrophy is not necessar-
ily associated with the rate of cognitive change in elderly 
subjects without dementia. 
 As to measures of the corpus callosum, they seem un-
suitable to predict future cognitive change in elderly with-
out dementia. To the best of our knowledge there is only 
one previous longitudinal study. Hampel et al.  [48] 
showed that AD patients have signiﬁ cantly greater rates 
of corpus callosum atrophy than controls. Two previous 
cross-sectional studies showed a non-signiﬁ cant reduc-
tion of callosal size in patients with QD and incipient 
dementia compared to controls  [49, 30] . The result has 
been replicated on an enlarged sample now. 
 A surprising result of this study was that a high base-
line SISCO was associated with decline, while a low base-
line SISCO was associated with improvement. This may 
be due to the ceiling effect. Participants with high test 
scores cannot improve. Other causes might be practice 
and regression to the mean on a repeated measurement. 
However, all participants that converted to dementia al-
ready had a SISCO in the lowest quartile of the whole 
sample at baseline. The opposite effects might have led 
to the weak degree of association between baseline SISCO 
and outcome. 
 Comparison of the outcome groups ‘decline’, ‘stability’ 
and ‘improvement’ will be discussed only shortly. The 
results correspond to the above-discussed ﬁ ndings be-
cause the deﬁ nition of the outcome groups was based on 
the annual change in SISCO. However, the differences 
between the groups in the brain volume measures were 
small and not signiﬁ cant. The lack of signiﬁ cance might 
be due to the use of a cutoff for the deﬁ nition of the out-
come groups. The cutoff was modelled on the normal 
distribution (which was present) but nevertheless arbi-
trary. In principle, this study provides evidence that im-
provement is a possible outcome of QD. This type of 
course is mostly neglected in imaging studies. According 
to present knowledge, 11–25% of patients with mild cog-
nitive deﬁ cits improve in cognitive function, and im-
provement seems to be stable  [50–52] . 
 This study used the rate of cognitive change as out-
come measure. This approach is unusual in neuroimaging 
studies (see above). Therefore the properties shall be 
pointed out that seem decisive. The outcome variable di-
rectly refers to the time course of the actual cognitive 
change. It allows to differentiate fast and slow progres-
sion, to describe improvement and changes within one 
diagnostic category. It might not only be relevant wheth-
er a patient develops a dementia syndrome. It might be 
also important at which rate changes occur. This question 
can only be answered when the outcome variable includes 
information about time. 
 Limits of the Study. The study was carried out within 
a 2-year period, which is a relatively short interval. It may 
be that some participants will develop dementia in the 
future. The deﬁ nition of the outcome variable – the an-
nual rate of cognitive change – was assumed to be inde-
pendent of the length of the follow-up interval. This is not 
necessarily the case, as cognitive decline might develop 
non-linearly. Moreover the statistic power of this study 
was limited. Particularly the comparison between par-
ticipants who declined and improved was based on only 
21 participants and is thus prone to statistical type II er-
ror. Because of the small sample size, it was impossible 
to determine measures of diagnostic accuracy and to anal-
yse the data in relation to the development of a dementia 
syndrome and to the change in the CDR global score. 
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 Conclusions 
 Measures of global brain volume are independently 
associated with the rate of cognitive change in elderly 
subjects without dementia. However, they seem to add 
only little information to clinical and psychometric infor-
mation. 
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